University of Illinois Chicago — Chicago, Illinois

Public research footprint of University of Illinois Chicago, compiled from the ClinicalTrials.gov public registry.

167

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Sickle Cell Disease · Advanced/Metastatic Non-Small Cell Lung Cancer · Disruptive Behavior Disorder, Childhood Onset · Immediate Dental Implant Placement

Recently updated registry entries

NCT05920356 — A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum… (Recruiting)
NCT06975865 — The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With… (Recruiting)
NCT07731659 — Physical Activity Intervention for Individuals Newly Diagnosed With MS (Not Yet Recruiting)

Work at University of Illinois Chicago?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.